650 results on '"Salama, Joseph K."'
Search Results
52. Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer
53. Ablative Approaches for Pulmonary Metastases
54. Is a single isocenter sufficient for volumetric modulated arc therapy radiosurgery when multiple intracranial metastases are spatially dispersed?
55. Radiation Toxicities and Management
56. Cancers of the Oral Cavity: Diagnosis and Treatment
57. Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415
58. Prophylactic cranial irradiation in elderly patients with small cell lung cancer: Findings from a North Central Cancer Treatment Group pooled analysis
59. Histology-Specific Metastasis
60. When Is a Biopsy-Proven Diagnosis Necessary Before Stereotactic Ablative Radiotherapy for Lung Cancer?: A Decision Analysis
61. ACR Appropriateness Criteria® thyroid carcinoma
62. Combining immunotherapy and radiotherapy for the STAR treatment
63. If at First You Don't Succeed—Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer
64. Moderately Hypofractionated Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: A New Way Forward for Dose Escalation?
65. Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
66. Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease
67. Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
68. Stereotactic Body Radiation Therapy for Treatment of Primary and Metastatic Pulmonary Malignancies
69. Stereotactic Body Radiotherapy in Patients With Stage I Non–Small-Cell Lung Cancer Aged 75 Years and Older: Retrospective Results From a Multicenter Consortium
70. Stereotactic Radiotherapy for Pulmonary Metastases
71. ACR Appropriateness Criteria® Locoregional therapy for resectable oropharyngeal squamous cell carcinomas
72. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers
73. Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy
74. Radiation therapy for oligometastatic non-small cell lung cancer
75. Statin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy
76. Comparing Outcomes of Oligometastases Treated with Hypofractionated Image-Guided Radiotherapy (HIGRT) with a Simultaneous Integrated Boost (SIB) Technique versus Metastasis Alone: A Multi-Institutional Analysis
77. Pulmonary Toxicity in Stage III Non-Small Cell Lung Cancer Patients Treated With High-Dose (74 Gy) 3-Dimensional Conformal Thoracic Radiotherapy and Concurrent Chemotherapy Following Induction Chemotherapy: A Secondary Analysis of Cancer and Leukemia Group B (CALGB) Trial 30105
78. ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck
79. ACR Appropriateness Criteria ® Retreatment of Recurrent Head and Neck Cancer After Prior Definitive Radiation : Expert Panel on Radiation Oncology–Head and Neck Cancer
80. Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer
81. Should We Target Oligometastatic EGFR-Mutated NSCLC with Radiotherapy before Administering Targeted Systemic Therapy?
82. Interpreting ORATOR: Lessons Learned From a Randomized Comparison of Primary Surgical and Radiation Approaches for Early-Stage Oropharyngeal Cancer
83. Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management
84. Irradiation and immunotherapy: From concept to the clinic
85. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE)
86. ACR Appropriateness Criteria® Aggressive Nonmelanomatous Skin Cancer of the Head and Neck
87. Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer
88. Chemoreirradiation for recurrent salivary gland malignancies
89. Facilitating the Transition to Independent Radiation Oncology Practice Through a Resident-Led, Veterans Affairs Teaching Hospital Service
90. Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer
91. Calculation and Prediction of the Effect of Respiratory Motion on Whole Breast Radiation Therapy Dose Distributions
92. Advances in Radiotherapy for Tumors Involving the Mediastinum
93. Effective Pain Control With Very Low Dose Palliative Radiation Therapy for Patients With Multiple Myeloma With Uncomplicated Osseous Lesions
94. OPINION: The oligometastatic state—separating truth from wishful thinking
95. Stereotactic body radiotherapy: A critical review for nonradiation oncologists
96. American college of radiology appropriateness criteria® treatment of stage I T1 glottic cancer
97. Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)
98. Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases
99. Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
100. Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting .
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.